Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOREMIFENE for Breast cancer recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where TOREMIFENE was used for Breast cancer recurrent.

Most Reported Side Effects for TOREMIFENE

Side Effect Reports % Deaths Hosp.
Fatigue 19 7.8% 0 7
Drug ineffective 17 6.9% 3 3
General physical health deterioration 14 5.7% 1 13
Atrial fibrillation 13 5.3% 0 12
Nausea 12 4.9% 0 3
Endometrial hyperplasia 10 4.1% 0 3
Hepatic function abnormal 10 4.1% 0 4
Oedema peripheral 10 4.1% 0 8
Drug-induced liver injury 9 3.7% 0 3
Endometrial thickening 9 3.7% 0 4
Myelosuppression 9 3.7% 0 6
Pyrexia 9 3.7% 0 8
Asthenia 8 3.3% 0 4
Pain 8 3.3% 0 5
Product use issue 8 3.3% 1 2

Other Indications for TOREMIFENE

Breast cancer (114) Product used for unknown indication (37) Invasive ductal breast carcinoma (17) Breast cancer metastatic (15) Desmoid tumour (6)

Other Drugs Used for Breast cancer recurrent

ERIBULIN (346) PALBOCICLIB (318) ABEMACICLIB (298) EVEROLIMUS (180) LETROZOLE (163) TRASTUZUMAB (157) FULVESTRANT (155) PACLITAXEL (124) DOCETAXEL (111) PERTUZUMAB (95)

Related Pages

TOREMIFENE Full Profile All Breast cancer recurrent Drugs TOREMIFENE Demographics TOREMIFENE Timeline